Prediction of Two Types of Unresponsive Gastroesophageal Reflux Disease to Proton Pump Inhibitor Therapy: Examination of Pre Treatment Factors

被引：0
|
作者：
Yagi, Nobuaki
Fujimoto, Sotaro
Tomatsuri, Naoya
Ando, Takashi
Naito, Yuji
Yoshikawa, Toshikazu
Oyamada, Hirokazu
Matsuyama, Kiichi
Ochiai, Jun
Maekawa, Takama
Oki, Keiichi
Ootsuka, Hirotomo
Tomii, Takashi
Fujia, Noriko
机构：
来源：
GASTROENTEROLOGY | 2009年 / 136卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A447 / A447
页数：1
相关论文
共 50 条
  • [31] Characteristics of Patients Initiating a New Proton Pump Inhibitor for Treatment of Gastroesophageal Reflux Disease (GERD)
    Gerson, Lauren
    Mody, Reema
    Eisenberg, Debra
    Hou, Likun
    Kamat, Siddhesh
    Singer, Joseph
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S398 - S398
  • [32] Low acid secretion is a risk of resistant to proton pump inhibitor treatment on gastroesophageal reflux disease
    Wada, Tsuneya
    Sasaki, Makoto
    Kataoka, Hiromi
    Ogasawara, Naotaka
    Kubota, Eiji
    Mori, Yoshinori
    Shimura, Takaya
    Mizoshita, Tsutomu
    Mizushima, Takashi
    Okamoto, Yasuyuki
    Kamiya, Takeshi
    Joh, Takashi
    GASTROENTEROLOGY, 2007, 132 (04) : A163 - A163
  • [33] Gastric mucosa atrophy decreased the efficacy of proton pump inhibitor treatment on gastroesophageal reflux disease
    Wada, Tsuneya
    Sasaki, Makoto
    Kataoka, Hiromi
    Ogasawara, Naotaka
    Kubota, Eiji
    Mori, Yoshinori
    Shimura, Takaya
    Mizoshita, Tsutomu
    Mizushima, Takashi
    Okamoto, Yasuyuki
    Kamiya, Takeshi
    Joh, Takashi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A153 - A153
  • [34] Predictors for the development of hypergastrinemia in the maintenance treatment of gastroesophageal reflux disease using a proton pump inhibitor
    Lee, Kwang Jae
    Jung, Da Hyun
    Kang, Seung Joo
    NEUROGASTROENTEROLOGY AND MOTILITY, 2024, 36
  • [35] Efficacy of Hangeshashinto on Gastrointestinal Symptoms in Patients With Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitor Therapy
    Takeuchi, Toshihisa
    Kawaguchi, Shinpei
    Takahashi, Yoshiaki
    Harada, Satoshi
    Ota, Kazuhiro
    Kojima, Yuichi
    Higuchi, Kazuhide
    GASTROENTEROLOGY, 2016, 150 (04) : S478 - S478
  • [36] Effects of rikkunshito on quality of life in patients with gastroesophageal reflux disease refractory to proton pump inhibitor therapy
    Kawai, Takashi
    Hirayama, Yoji
    Oguchi, Aiko
    Ishii, Fumi
    Matushita, Masanao
    Kitayama, Naoya
    Morishita, Shinji
    Hiratsuka, Noboru
    Ohata, Ken
    Konishi, Hiroyuki
    Kishino, Maiko
    Nakamura, Shinichi
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2017, 60 (02) : 143 - 145
  • [37] Low levels of adherence with proton pump inhibitor therapy contribute to therapeutic failure in gastroesophageal reflux disease
    Dal-Paz, K.
    Moraes-Filho, J. P.
    Navarro-Rodriguez, T.
    Eisig, J. N.
    Barbuti, R.
    Quigley, E. M. M.
    DISEASES OF THE ESOPHAGUS, 2012, 25 (02) : 107 - 113
  • [38] Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms
    Delshad, Sean D.
    Almario, Christopher V.
    Chey, William D.
    Spiegel, Brennan M. R.
    GASTROENTEROLOGY, 2020, 158 (05) : 1250 - +
  • [39] Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions
    Mermelstein, Joseph
    Mermelstein, Alanna Chait
    Chait, Maxwell M.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2018, 11 : 119 - 134
  • [40] Symptom Predictability in Gastroesophageal Reflux Disease and Role of Proton Pump Inhibitor Test
    Estores, David S.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2014, 43 (01) : 27 - +
12345